- The program is tentative and subject to change.
- 모든 세션에는 통역(ENG->KOR)이 제공 됩니다. (Meet the Expert Session, Oral Session 제외)
September 21 (Thu)
08:00-10:00
Physician Track 1
Grand Ballroom B
Chair(s)
Ashita Tolwani (USA)
Seung Hyeok Han (Korea)
Seung Hyeok Han (Korea)
09:40-10:00
Q&A Session
September 21 (Thu)
08:00-10:00
Nurse Track 1
Room 306
Chair(s)
Ian Baldwin (Australia)
Dae Eun Choi (Korea)
Dae Eun Choi (Korea)
09:00-09:20
Why Polymyxin B Is Working So Well in Gram Positive Infections?
Patrick Honore (Belgium)
09:40-10:00
Q&A Session
September 21 (Thu)
10:00-10:30
Coffee break
September 21 (Thu)
10:30-12:30
Physician Track 2
Grand Ballroom B
Chair(s)
Marlies Ostermann (UK)
Jong Hyun Jhee (Korea)
Jong Hyun Jhee (Korea)
12:10-12:30
Q&A Session
September 21 (Thu)
10:30-12:30
Nurse Track 2
Room 306
Chair(s)
Jorge Cerda (USA)
Harin Rhee (Korea)
Harin Rhee (Korea)
11:10-11:30
Patient Mobilization and Rehabilitation
Keith Wille (USA)
11:30-11:50
Developing Quality Measures for CRRT
Ian Baldwin (Australia)
12:10-12:30
Q&A Session
September 21 (Thu)
12:30-13:30
Luncheon Symposium 1 (Astrazeneca)
Is SGLT2i Safe from Acute Kidney Injury?
Is SGLT2i Safe from Acute Kidney Injury?
Grand Ballroom B
Chair(s)
Sejoong Kim (Korea)
12:30-13:30
Is SGLT2i Safe from Acute Kidney Injury?
Jang-Hee Cho (Korea)
September 21 (Thu)
12:30-13:30
Satellite Symposium (BioPorto)
Integrating Damage Biomarkers into AKI Clinical Assessment
Integrating Damage Biomarkers into AKI Clinical Assessment
Room 306
12:30-13:00
Integrating Damage Biomarkers into AKI Clinical Assessment
Marlies Ostermann (UK)
September 21 (Thu)
13:30-14:00
Coffee break
September 21 (Thu)
14:00-17:30
Interactive Track
Grand Ballroom B
Chair(s)
Ashita Tolwani (USA)
Jong-Woo Yoon (Korea)
Jong-Woo Yoon (Korea)
14:00-14:30
CRRT Device Overview, Machine Priming, Circuit Set Up, Programming to Match Orders
Chan-Young Jung (Korea)
Soo Yeon Kim (Korea)
Soo Yeon Kim (Korea)
15:30-16:00
Intermission
16:00-16:30
Therapy Dosing, Fluid Balance, Monitoring, Troubleshooting Alarms, Therapy Discontinuation
Kipyo Kim (Korea)
Jiwon Kim (Korea)
Jiwon Kim (Korea)
16:30-17:00
Interactive Case Discussion 3
Jeong-Hoon Lim (Korea)
17:00-17:30
Interactive Case Discussion 4
Tai Yeon Koo (Korea)
September 21 (Thu)
14:00-17:00
Pediatric Track
Room 306
Chair(s)
Stuart Goldstein (USA)
Jae Il Shin (Korea)
Jae Il Shin (Korea)
14:00-14:30
Pediatric: How to Run CRRT in Pediatric Patients
Stuart Goldstein (USA)
15:30-16:00
Intermission
16:00-16:30
Pediatric: Simulation
Jae Il Shin (Korea)
September 21 (Thu)
18:00-19:30
Welcome Reception
Auditorium Lobby & Sky Garden, 5F
September 22 (Fri)
08:00-08:30
Opening Ceremony & Remark
Grand Ballroom B
Chair(s)
Chun Soo Lim (Korea)
Chan-Duck Kim (Korea)
Chan-Duck Kim (Korea)
08:00-08:10
Opening Remark
Chan-Duck Kim (Korea)
September 22 (Fri)
08:30-10:00
Workshop 1
Starting, Transitioning, and Stopping RRT for AKI: Science and Art
Starting, Transitioning, and Stopping RRT for AKI: Science and Art
Grand Ballroom B
08:30-10:00
Starting, Transitioning, and Stopping RRT for AKI: Science and Art
Ravindra Mehta (USA)
Nuttha Lumlertgul (Thailand)
Nuttha Lumlertgul (Thailand)
September 22 (Fri)
08:30-10:00
Workshop 2
Precision Solute Control and Dynamic Dosing With CRRT
Precision Solute Control and Dynamic Dosing With CRRT
Room 306
08:30-10:00
Precision Solute Control and Dynamic Dosing With CRRT
Manish Kaushik (Singapore)
Keith Wille (USA)
Ian Baldwin (Australia)
Keith Wille (USA)
Ian Baldwin (Australia)
September 22 (Fri)
08:30-10:00
Workshop 3
Managing Patients With Combined Kidney and Liver Failure
Managing Patients With Combined Kidney and Liver Failure
Room 314
08:30-10:00
Managing Patients With Combined Kidney and Liver Failure
Mitra Nadim (USA)
Akash Deep (UK)
Hye Ryoun Jang (Korea)
Akash Deep (UK)
Hye Ryoun Jang (Korea)
September 22 (Fri)
10:00-10:30
Coffee break
September 22 (Fri)
10:30-12:30
Plenary Session 1
Organ Dysfunction in the Critically Ill Patient: Emerging Concepts
Organ Dysfunction in the Critically Ill Patient: Emerging Concepts
Grand Ballroom B
Chair(s)
Yong-Lim Kim (Korea)
Sejoong Kim (Korea)
Sejoong Kim (Korea)
11:45-12:00
Micronutrient Deficiency: Cause for Concern?
Nuttha Lumlertgul (Thailand)
September 22 (Fri)
12:30-13:30
Luncheon Symposium 2 (FMC Korea)
Dysnatraemia Management in CKRT
Dysnatraemia Management in CKRT
Grand Ballroom B
Chair(s)
Sang-kyung Jo (Korea)
12:30-13:20
Dysnatremias in Continuous Kidney Replacement Therapy
Lenar Yessayan (USA)
September 22 (Fri)
12:30-13:30
Luncheon Symposium 3 (SK Chemicals)
Nafamostat as an Anticoagulant in CRRT
Nafamostat as an Anticoagulant in CRRT
Room 306
Chair(s)
Ho Sik Shin (Korea)
September 22 (Fri)
12:30-13:30
Luncheon Symposium 4 (Otsuka)
Recent Updates in Therapeutic Approach Using Tolvaptan for ADPKD
Recent Updates in Therapeutic Approach Using Tolvaptan for ADPKD
Room 314
Chair(s)
Yun Kyu Oh (Korea)
12:30-13:30
Recent Updates in Therapeutic Approach Using Tolvaptan for ADPKD
Yaerim Kim (Korea)
September 22 (Fri)
13:30-15:30
Plenary Session 2
Acute Kidney Injury (AKI): Pathophysiology
Acute Kidney Injury (AKI): Pathophysiology
Grand Ballroom B
Chair(s)
Seungyeup Han (Korea)
Won Min Hwang (Korea)
Won Min Hwang (Korea)
13:30-13:45
Inflammatory Pathophysiology of AKI
John Kellum (USA)
14:15-14:30
Biomarker as Prognostic Enrichment Targets for AKI Sub Phenotypes: Another Gemstone in the Jewelry Box
Vin-Cent Wu (Taiwan)
14:45-15:00
Angiotensin II in AKI: Perpetrator or Savior
John Kellum (USA)
15:15-15:30
Levosimendan and Its Relevant Mechanism in AKI
Patrick Honore (Belgium)
September 22 (Fri)
15:30-16:00
Coffee break
September 22 (Fri)
16:00-17:00
Symposium 1
Controversies in AKI
Controversies in AKI
Grand Ballroom B
Chair(s)
Marlies Ostermann (UK)
Byung Ha Chung (Korea)
Byung Ha Chung (Korea)
16:00-16:15
Economics of AKI: What Makes It So Costly?
John Kellum (USA)
16:15-16:30
Vasopressor & Vasodilator in AKI
Gang Jee Ko (Korea)
16:45-17:00
Q&A Session
Yohan Park (Korea)
Ji Hye Kim (Korea)
Samel Park (Korea)
Ji Hye Kim (Korea)
Samel Park (Korea)
September 22 (Fri)
16:00-17:00
Symposium 2
Solute & Volume Control in AKI
Solute & Volume Control in AKI
Room 306
Chair(s)
Kianoush Kashani (USA)
Jeonghwan Lee (Korea)
Jeonghwan Lee (Korea)
16:45-17:00
Q&A Session
Kyeong Min Kim (Korea)
Seon Ha Baek (Korea)
Haekyung Lee (Korea)
Seon Ha Baek (Korea)
Haekyung Lee (Korea)
September 22 (Fri)
16:00-17:00
Symposium 3
Bench to Bedside
Bench to Bedside
Room 314
Chair(s)
Kent Doi (Japan)
Jang-Hee Cho (Korea)
Jang-Hee Cho (Korea)
16:00-16:15
Exosome
Tae-Hyun Yoo (Korea)
16:45-17:00
Q&A Session
Seok Hui Kang (Korea)
Hyung Duk Kim (Korea)
Soie Kwon (Korea)
Hyung Duk Kim (Korea)
Soie Kwon (Korea)
September 22 (Fri)
17:00-18:30
Poster Walk & Oral 1
Grand Ballroom A / Booth A
Chair(s)
Vin-Cent Wu (Taiwan)
Jong Hyun Jhee (Korea)
Jong Hyun Jhee (Korea)
17:00-17:12
Effectiveness of Multidisciplinary Post-Acute Kidney Injury Clinic on Awareness and Knowledge in Acute Kidney Injury Survivors
Peerapat Thanapongsatorn (Thailand)
17:12-17:24
Mortality associated with the neutrophil-lymphocyte ratio in septic acute kidney injury requiring continuous renal replacement therapy
Jeongin Song (Korea)
17:24-17:36
Efficacy of AGB-100 TGF- type I receptor (ALK5) inhibitor using renal fibrosis on a chip model
EUN-JEONG KWON (Korea)
17:36-17:48
Beneficial Effects of Angiotensin Receptor-Neprilysin Inhibitors in Patients with Acute Kidney Disease and Heart Failure
Jui-Yi Chen (Taiwan)
17:48-18:00
Prediction and management of acute kidney injury with explainable artificial intelligence (PRIME): a study protocol for a randomized controlled trial
Giae Yun (Korea)
18:00-18:12
Korean multicenter study of data repository derived from patients with acute kidney injury requiring continuous kidney replacement therapy to overcome transition to acute kidney disease
Jung Nam An (Korea)
September 22 (Fri)
17:00-18:30
Poster Walk & Oral 2
Grand Ballroom A / Booth B
Chair(s)
Kent Doi (Japan)
Seung Seok Han (Korea)
Seung Seok Han (Korea)
17:00-17:12
Evaluation of risk stratification for acute kidney injury: A comparative analysis of EKFC 2009 and 2021 CKD-EPI glomerular filtration estimating equations
Jeong Min Cho (Republic of Korea)
17:12-17:24
Early initiation of Continuous Renal Replacement Therapy Improves Survival in Patients with Acute Kidney Injury Accompanied by Heart Failure
Chae Won Kim (Republic of Korea)
17:24-17:36
A role of nafamostat anticoagulation for CRRT in critically ill patients with a bleeding tendency. Introduction
TAEIL KIM (Republic of Korea)
17:36-17:48
The effect of CRRT with oXiris filter in patients with AKI combined septic condition: Case Report Series
Seyoung Ryou (Republic of Korea)
17:48-18:00
Effects of Continuous Renal Replacement Therapy for Volume Management on Short and Long-Term Outcomes of Patients Treated with Extracorporeal Membrane Oxygenation: A Propensity-Score Matched Analysis
Nghia Nguyen (Vietnam)
18:00-18:12
Platelet-to-Lymphocyte Ratio and In-Hospital Mortality in Patients with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: A Retrospective Observational Cohort Study
You Hyun Jeon (Republic of Korea)
September 22 (Fri)
17:00-18:30
Poster Walk & Oral 3
Grand Ballroom A / Booth C
Chair(s)
Patrick Honore (Belgium)
Jwa-Kyung Kim (Korea)
Jwa-Kyung Kim (Korea)
17:00-17:12
Differences in incidence characteristics and outcomes in acute kidney injury between medical and surgical patients
YEJI LEE (Republic of Korea)
17:12-17:24
Clinical Outcomes of Hemoperfusion Among COVID-19 Severe Patients in a Tertiary Hospital
Maryjo Therese Castillejos (Philippines)
17:24-17:36
Association between systemic inflammation biomarkers and mortality in patients with septic AKI receiving intensive care and continuous kidney replacement therapy: Results from the RENERGY study
Chan-Young Jung (Republic of Korea)
17:36-17:48
Mortality Prediction of Plasma Presepsin in Septic Patients requiring Continuous Renal Replacement Therapy
Gi-Beop Lee (Republic of Korea)
17:48-18:00
The Role of the Pharmacist in the Multidisciplinary Approach to the Acute Kidney Injury Survivor: a Pilot Study in Taiwan
Ting Wang (Taiwan)
18:00-18:12
The development of Chula CRRT virtual reality training program: a novel tool for future CRRT training program
Khanittha Yimsangyad (Thailand)
18:12-18:24
Cost analysis of in-house production of continuous renal replacement therapy dialysis and replacement fluids
Khanittha Yimsangyad (Thailand)
September 23 (Sat)
07:30-08:15
Meet the Expert 1
How Do I Assess the Volume Status of My Patient?
How Do I Assess the Volume Status of My Patient?
Room 505
07:30-08:15
How Do I Assess the Volume Status of My Patient?
Kianoush Kashani (USA)
Claudio Ronco (Italy)
Claudio Ronco (Italy)
September 23 (Sat)
07:30-08:15
Meet the Expert 2
Deciding Who Needs to Start and Stop RRT
Deciding Who Needs to Start and Stop RRT
Room 504
07:30-08:15
Deciding Who Needs to Start and Stop RRT
Marlies Ostermann (UK)
Matthieu Legrand (USA)
Matthieu Legrand (USA)
September 23 (Sat)
07:30-08:15
Meet the Expert 3
How Do I Manage the Patient With Septic AKI?
How Do I Manage the Patient With Septic AKI?
Room 503
07:30-08:15
How Do I Manage the Patient With Septic AKI?
Patrick Honore (Belgium)
John Kellum (USA)
John Kellum (USA)
September 23 (Sat)
08:15-08:30
Break
September 23 (Sat)
08:30-10:00
Workshop 4
Personalized Fluid Management With CRRT
Personalized Fluid Management With CRRT
Grand Ballroom B
08:30-10:00
Personalized Fluid Management With CRRT
Ravindra Mehta (USA)
Nuttha Lumlertgul (Thailand)
Sung Yoon Lim (Korea)
Nuttha Lumlertgul (Thailand)
Sung Yoon Lim (Korea)
September 23 (Sat)
08:30-10:00
Workshop 5
Improving Care for Patients After Hospitalization for AKI
Improving Care for Patients After Hospitalization for AKI
Room 306
08:30-10:00
Improving Care for Patients After Hospitalization for AKI
Nattachai Srisawat (Thailand)
Vin-Cent Wu (Taiwan)
Harin Rhee (Korea)
Vin-Cent Wu (Taiwan)
Harin Rhee (Korea)
September 23 (Sat)
08:30-10:00
Workshop 6
Managing the Heart Failure Patient With Worsening Renal Function (WRF)
Managing the Heart Failure Patient With Worsening Renal Function (WRF)
Room 314
08:30-10:00
Managing the Heart Failure Patient With Worsening Renal Function (WRF)
Amir Kazory (USA)
Claudio Ronco (Italy)
Rajasekara Chakravarthi (India)
Claudio Ronco (Italy)
Rajasekara Chakravarthi (India)
September 23 (Sat)
10:00-10:30
Coffee break
September 23 (Sat)
10:30-12:30
Plenary Session 3
Challenges in ICU Management
Challenges in ICU Management
Grand Ballroom B
Chair(s)
Rajasekara Chakravarthi (India)
Jihyun Yang (Korea)
Jihyun Yang (Korea)
10:30-10:45
Integrated Hemodynamic Assessment and Management in the ICU
Kianoush Kashani (USA)
10:45-11:00
Volume Management in Critically Ill: To Fill or Not to Fill
Amir Kazory (USA)
11:00-11:15
The Role of Renal Functional Reserve (RFR) in AKI
Vincenzo Cantaluppi (Italy)
11:15-11:30
Bicarbonate: The good, the Bad, and the Ugly
Hyung Woo Kim (Korea)
12:00-12:30
The Journey from Diffusion to Adsorption in Blood Purification
Claudio Ronco (Italy)
September 23 (Sat)
12:30-13:30
Luncheon Symposium 5 (Baxter)
New Evolution in Blood Purification
New Evolution in Blood Purification
Grand Ballroom B
Chair(s)
Ravindra Mehta (USA)
12:30-13:00
Clinical Challenges and Unmet Needs in the Management of Sepsis and Septic Shock
Sung Yoon Lim (Korea)
13:00-13:30
Targeting Hemodynamic Improvement in Septic Shock Patients
Nattachai Srisawat (Thailand)
September 23 (Sat)
12:30-13:30
Luncheon Symposium 6 (Kyowa Kirin)
A New Generation of Iron-Based P Binder
A New Generation of Iron-Based P Binder
Room 306
Chair(s)
Eun Hui Bae (Korea)
12:30-13:30
A New Generation of Iron-Based P Binder
Seung Seok Han (Korea)
September 23 (Sat)
12:30-13:30
Luncheon Symposium 7 (HK inno.N)
Optimal Dosage of Kremezin® in CKD
Optimal Dosage of Kremezin® in CKD
Room 314
Chair(s)
Kyubok Jin (Korea)
September 23 (Sat)
13:30-15:30
Plenary Session 4
Challenges and Controversies in Renal Support and CRRT
Challenges and Controversies in Renal Support and CRRT
Grand Ballroom B
Chair(s)
Ashita Tolwani (USA)
Jwa-Kyung Kim (Korea)
Jwa-Kyung Kim (Korea)
13:30-13:45
Harmonizing Nomenclature for ECOS Consensus Recommendations
Claudio Ronco (Italy)
13:45-14:00
Interpreting the Timing of Dialysis Trials: What Criteria Should We Use
Matthieu Legrand (USA)
14:00-14:15
Personalizing Dialysis Application: The Way Forward
Ravindra Mehta (USA)
14:15-14:30
AKI and RRT in Patients Receiving ECMO
Dong Jung Kim (Korea)
14:30-14:45
AKD Care and Clinical Outcome – Time to Ditch the Dogma
Vin-Cent Wu (Taiwan)
14:45-15:00
Nafamostat Mesylate Anticoagulation for CRRT
Harin Rhee (Korea)
15:00-15:15
ADQI 27 Report: Digital Health in AKI
Kianoush Kashani (USA)
September 23 (Sat)
15:30-16:00
Coffee break
September 23 (Sat)
16:00-17:00
Symposium 4
Innovations in Caring for Patients With Electrolyte Disturbance
Innovations in Caring for Patients With Electrolyte Disturbance
Grand Ballroom B
Chair(s)
Matthieu Legrand (USA)
Junseok Jeon (Korea)
Junseok Jeon (Korea)
16:00-16:25
Innovations in Caring for Patients With Dysnatremias
Nuttha Lumlertgul (Thailand)
16:25-16:50
Innovations in Caring for Patients With Dyschloremia
Sung Yoon Lim (Korea)
16:50-17:00
Q&A Session
Bong Soo Park (Korea)
Kyungho Lee (Korea)
Young Su Joo (Korea)
Kyungho Lee (Korea)
Young Su Joo (Korea)
September 23 (Sat)
16:00-17:00
Symposium 5
Oncology in ICU: Considerations in Managing Critically Ill Patients With Cancer
Oncology in ICU: Considerations in Managing Critically Ill Patients With Cancer
Room 306
Chair(s)
John Kellum (USA)
Woo Hyun Cho (Korea)
Woo Hyun Cho (Korea)
16:00-16:25
Practical Considerations in Managing AKI in Patients With Cancer
Stuart Goldstein (USA)
16:25-16:50
Ethical Considerations in Managing Critically Ill Patients With Cancer
Ryoung-Eun Ko (Korea)
16:50-17:00
Q&A Session
Il Young Kim (Korea)
Byunghyuk Yu (Korea)
Seungwoo Chung (Korea)
Byunghyuk Yu (Korea)
Seungwoo Chung (Korea)
September 23 (Sat)
16:00-17:00
Symposium 6
CRRT Korean Guideline
CRRT Korean Guideline
Room 314
Chair(s)
Chan-Duck Kim (Korea)
Kyung Pyo Kang (Korea)
Kyung Pyo Kang (Korea)
16:00-16:10
PICO 1
Donghyuk Kang (Korea)
16:10-16:20
PICO 2
Jangwook Lee (Korea)
16:20-16:30
PICO 3
Hyung Woo Kim (Korea)
16:30-16:40
PICO 4
Sunghoon Park (Korea)
16:40-16:50
PICO 5
Seong Geun Kim (Korea)
16:50-17:00
Q&A Session
Hyung Eun Son (Korea)
Yongjin Yi (Korea)
Ji Young Ryu (Korea)
Yongjin Yi (Korea)
Ji Young Ryu (Korea)
September 23 (Sat)
17:00-18:30
Poster Walk & Oral 4
Grand Ballroom A / Booth A
Chair(s)
Etienne Macedo (USA)
Sung Yoon Lim (Korea)
Sung Yoon Lim (Korea)
17:00-17:10
Development of Artificial Intelligence Model for the Prediction of Acute Kidney Injury Acute Kidney Disease and Chronic Kidney Disease after General Anesthesia Surgery
Ji Won Min (Republic of Korea)
17:10-17:20
Machine Learning-Based Prediction of Acute Kidney Injury Recovery within 7 Days in AKI Patients
InYong Jeong (Republic of Korea)
17:30-17:40
PROCALCITONIN AS A PREDICTIVE FACTOR FOR ACUTE KIDNEY INJURY IN COVID 19 PATIENTS; A SINGLE STUDY IN INDONESIA
Riri Andri Muzasti (Indonesia)
17:40-17:50
Role of increased neutrophil extracellular trap formation on acute kidney injury in COVID-19 patients
Jwa Kyung Kim (Republic of Korea)
18:00-18:10
Urinary Calprotectin Detects Severe Acute Kidney Injury in Critically Ill Patients Following Non-Cardiac Surgery: A Prospective Cohort Study
Lingyi Xu (China)
18:10-18:20
Effects of Cardiovascular Outcomes of Sacubitril-valsartan in patients with Acute Kidney Injury
Hyo Jeong Kim (Republic of Korea)
September 23 (Sat)
17:00-18:30
Poster Walk & Oral 5
Grand Ballroom A / Booth B
Chair(s)
Jorge Cerda (USA)
Yang-Gyun Kim (Korea)
Yang-Gyun Kim (Korea)
17:00-17:12
Time-restricted feeding attenuates cisplatin-induced acute kidney injury through the regulation of cellular senescence
Kyu Won Jang (Republic of Korea)
17:12-17:24
Kidney ischemia reperfusion injury induces disruption of cholangiocyte primary cilia via oxidative stress
Yong Kwon Han (Republic of Korea)
17:24-17:36
Expansion and Characterization of Regulatory T cell Populations from Acute Kidney Injury Patients
Byung Hwa Park (Republic of Korea)
17:36-17:48
Inhibition of histone lysine demethylases 5 attenuates acute kidney injury but not acute kidney disease or chronic kidney disease
So Young Lee (Republic of Korea)
17:48-18:00
Influence of eGFR and MELD Score on Terlipressin Treatment Outcomes in Patients with Decompensated Liver Cirrhosis
Seung Yun Chae (Republic of Korea)
18:00-18:12
The Importance of Hyperuricemia Control : Data from Undergoing Continuous Renal Replacement Therapy
Soie Kwon (Republic of Korea)
September 23 (Sat)
17:00-18:30
Poster Walk & Oral 6
Grand Ballroom A / Booth C
Chair(s)
Matthieu Legrand (USA)
Eun Hui Bae (Korea)
Eun Hui Bae (Korea)
17:00-17:12
Clinical impacts of sarcopenia based on psoas muscle mass in critically ill patients undergoing continuous renal replacement therapy
BeongWoo Kim (Republic of Korea)
17:12-17:24
Prognostic nutritional index and the risk of mortality in patients undergoing continuous kidney replacement therapy
Hyo Jeong Kim (Republic of Korea)
17:24-17:36
The impacts of skeletal muscle mass and quality on kidney recovery of patients with acute kidney injury receiving continuous renal replacement therapy
Jin Hyuk Paek (Republic of Korea)
17:36-17:48
Intradialytic hypotension and worse outcomes in patients with acute kidney injury requiring intermittent hemodialysis
Yeongwon Park (Republic of Korea)
17:48-18:00
Phosphate is a predictor of mortality in acute kidney injury patients undergoing continuous kidney replacement therapy and has U-shaped association in patients with high severity: a multicenter retrospective study
Young Hwan Lee (Republic of Korea)
18:00-18:12
Mortality of elderly patients with acute kidney injury undergoing continuous renal replacement therapy; is age a risk factor
Ji Hye Kim (Republic of Korea)
18:12-18:24
The impact of C-reactive protein-to-albumin ratio on mortality in patients with acute kidney injury requiring continuous renal replacement therapy: A multicenter retrospective study
Youn Ju Kim (Republic of Korea)
September 24 (Sun)
07:30-08:15
Meet the Expert 4
How Do I Dose Volume During CRRT?
How Do I Dose Volume During CRRT?
Room 505
07:30-08:15
How Do I Dose Volume During CRRT?
Marlies Ostermann (UK)
Ravindra Mehta (USA)
Ravindra Mehta (USA)
September 24 (Sun)
07:30-08:15
Meet the Expert 5
How Do I Manage the Oliguric Patient?
How Do I Manage the Oliguric Patient?
Room 504
07:30-08:15
How Do I Manage the Oliguric Patient?
Amir Kazory (USA)
Etienne Macedo (USA)
Etienne Macedo (USA)
September 24 (Sun)
07:30-08:15
Meet the Expert 6
Pediatric AKI and CRRT
Pediatric AKI and CRRT
Room 503
07:30-08:15
Pediatric AKI and CRRT
Stuart Goldstein (USA)
Akash Deep (UK)
Akash Deep (UK)
September 24 (Sun)
08:15-08:30
Break
September 24 (Sun)
08:30-10:30
Plenary Session 5
Improving Outcomes in AKI
Improving Outcomes in AKI
Grand Ballroom B
Chair(s)
Claudio Ronco (Italy)
Won Min Hwang (Korea)
Won Min Hwang (Korea)
08:45-09:00
AKI Outcomes in Resource Limited Settings: In-SEA Study
Nattachai Srisawat (Thailand)
09:15-09:30
Adjusting Immunosuppressants in AKI
Jeong-Hoon Lim (Korea)
09:30-09:45
Management of AKI in Elderly Patients
Jin Hyuk Paek (Korea)
10:00-10:15
Stand Alone Renal Doppler to Assess the Risk of AKI Is Dead
Patrick Honore (Belgium)
September 24 (Sun)
10:30-11:00
Coffee break
September 24 (Sun)
11:00-12:30
Plenary Session 6
Future Trends in CRRT and Critical Care
Future Trends in CRRT and Critical Care
Grand Ballroom B
Chair(s)
Vincenzo Cantaluppi (Italy)
Jun Young Do (Korea)
Jun Young Do (Korea)
11:15-11:30
How Can We Improve Medullary Oxygenation?
Patrick Honore (Belgium)
September 24 (Sun)
12:30-13:00
Closing Ceremony
Grand Ballroom B
12:30-12:40
Best Abstract Award Ceremony
12:40-12:50
Closing Report
Sejoong Kim (Korea)
12:50-12:55
Closing Remark
Ravindra Mehta (USA)
12:55-13:00
Closing Remark
Chan-Duck Kim (Korea)
Chair(s)
Jang-Hee Cho (Korea)